Haythem Najah1,2, Brice Malgras3,4, Anthony Dohan4,5, Caroline Gronnier6, Clarisse Eveno3,4, Marc Pocard3,4. 1. Department of Oncologic & Digestive Surgery, AP-HP, Hospital Lariboisière, 2 Rue Ambroise Paré, 75475, Paris Cedex 10, France. haythem.najah@gmail.com. 2. Université Paris Diderot, Sorbonne Paris Cité, CART, INSERM U965, 74575, Paris, France. haythem.najah@gmail.com. 3. Department of Oncologic & Digestive Surgery, AP-HP, Hospital Lariboisière, 2 Rue Ambroise Paré, 75475, Paris Cedex 10, France. 4. Université Paris Diderot, Sorbonne Paris Cité, CART, INSERM U965, 74575, Paris, France. 5. Department of Abdominal Imaging, Hôpital Lariboisière-AP-HP, 2 Rue Ambroise Paré, 75475, Paris Cedex 10, France. 6. Department of Digestive and Endocrine Surgery, Bordeaux University Hospital, Hôpital Haut lévêque, Centre Magellan, 33604, Pessac Cedex, France.
Abstract
BACKGROUND: The outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) depends on the extent of peritoneal metastases (PM) and the completeness of cytoreduction (CCR). The role of preoperative assessment of PM is to identify potential candidates for CRS/HIPEC and to prevent unwarranted laparotomy for those who are not. Laparoscopy has been utilized for that purpose but with concerns related to technical difficulties and risk of trocar site metastases. Single-incision laparoscopic peritoneal exploration (SILPE) has not yet been evaluated in this setting. METHODS: This single-center retrospective study examined patients from January 2011 to December 2015 who underwent SILPE for diagnosis and staging of PM. Preoperative, intraoperative, and postoperative data were collected. For the patients who underwent subsequent laparotomy, a comparison between SILPE and laparotomy findings was made. RESULTS: A total of 183 SILPE were performed. Primary sites were mostly colorectal in 72 cases (39.3%) and gastric in 47 (25.7%). Overall, 157 patients (85.8%) had at least one prior abdominal surgery and 48 (26.2%) had 3 or more. SILPE was successfully achieved in 90.2% of the cases. Two (1.2%) intraoperative complications and five (3%) postoperative complications were observed. Eighty-one patients had laparotomy, with a median of 27 days between SILPE and laparotomy (4-162 days). The peritoneal carcinomatosis index PCI was 9.7 ± 7.5 at SILPE, and 13.5 ± 9.6 at laparotomy. The positive predictive value of SILPE to predict CCR was 79.5%. SILPE sensitivity was 75% and specificity 97%. The lowest sensitivity was in regions 9-12 ranging from 44 to 53%. CONCLUSION: SILPE can be safely incorporated in the management of patients with PM. It is a safe and feasible staging tool, allowing for preventing unwarranted laparotomy for patients not deemed candidate for CRS/HIPEC. Even though it may underestimate PCI, SILPE accurately predicts the possibility of CCR.
BACKGROUND: The outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) depends on the extent of peritoneal metastases (PM) and the completeness of cytoreduction (CCR). The role of preoperative assessment of PM is to identify potential candidates for CRS/HIPEC and to prevent unwarranted laparotomy for those who are not. Laparoscopy has been utilized for that purpose but with concerns related to technical difficulties and risk of trocar site metastases. Single-incision laparoscopic peritoneal exploration (SILPE) has not yet been evaluated in this setting. METHODS: This single-center retrospective study examined patients from January 2011 to December 2015 who underwent SILPE for diagnosis and staging of PM. Preoperative, intraoperative, and postoperative data were collected. For the patients who underwent subsequent laparotomy, a comparison between SILPE and laparotomy findings was made. RESULTS: A total of 183 SILPE were performed. Primary sites were mostly colorectal in 72 cases (39.3%) and gastric in 47 (25.7%). Overall, 157 patients (85.8%) had at least one prior abdominal surgery and 48 (26.2%) had 3 or more. SILPE was successfully achieved in 90.2% of the cases. Two (1.2%) intraoperative complications and five (3%) postoperative complications were observed. Eighty-one patients had laparotomy, with a median of 27 days between SILPE and laparotomy (4-162 days). The peritoneal carcinomatosis index PCI was 9.7 ± 7.5 at SILPE, and 13.5 ± 9.6 at laparotomy. The positive predictive value of SILPE to predict CCR was 79.5%. SILPE sensitivity was 75% and specificity 97%. The lowest sensitivity was in regions 9-12 ranging from 44 to 53%. CONCLUSION: SILPE can be safely incorporated in the management of patients with PM. It is a safe and feasible staging tool, allowing for preventing unwarranted laparotomy for patients not deemed candidate for CRS/HIPEC. Even though it may underestimate PCI, SILPE accurately predicts the possibility of CCR.
Entities:
Keywords:
Laparoendoscopic single-site surgery; Minimally invasive surgery; Peritoneal cancer index; Peritoneal carcinomatosis; Peritoneoscopy; Single-incision laparoscopic surgery
Authors: B Menassel; A Duclos; G Passot; A Dohan; C Payet; S Isaac; P J Valette; O Glehen; P Rousset Journal: Eur J Surg Oncol Date: 2016-01-22 Impact factor: 4.424
Authors: Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder Journal: J Clin Oncol Date: 2003-10-15 Impact factor: 44.544
Authors: Haythem Najah; Réa Lo Dico; Marion Grienay; Anthony Dohan; Xavier Dray; Marc Pocard Journal: Surg Endosc Date: 2015-12-10 Impact factor: 4.584
Authors: Gabriel Liberale; Sophie Vankerckhove; Maria Gomez Caldon; Bissan Ahmed; Michel Moreau; Issam El Nakadi; Denis Larsimont; Vincent Donckier; Pierre Bourgeois Journal: Ann Surg Date: 2016-12 Impact factor: 12.969